News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
231,707 Results
Type
Article (11291)
Company Profile (28)
Press Release (220388)
Section
Business (76148)
Career Advice (1055)
Deals (14484)
Drug Delivery (30)
Drug Development (35097)
Employer Resources (38)
FDA (6027)
Job Trends (5786)
News (129080)
Policy (9629)
Tag
Academia (748)
Alliances (10098)
Alzheimer's disease (510)
Approvals (6009)
Artificial intelligence (47)
Bankruptcy (92)
Best Places to Work (5084)
Biosimilars (36)
Breast cancer (68)
Cancer (602)
Cardiovascular disease (36)
Career advice (833)
Cell therapy (108)
Clinical research (29141)
Collaboration (154)
Compensation (171)
COVID-19 (924)
Data (625)
Diabetes (82)
Diagnostics (2199)
Earnings (54060)
Events (36715)
Executive appointments (97)
FDA (6281)
Funding (136)
Gene therapy (76)
GLP-1 (300)
Government (1374)
Healthcare (7253)
Infectious disease (959)
Inflammatory bowel disease (47)
Interviews (191)
IPO (9100)
Job creations (964)
Job search strategy (739)
Layoffs (136)
Legal (1691)
Lung cancer (110)
Manufacturing (59)
Medical device (5040)
Medtech (5040)
Mergers & acquisitions (5489)
Metabolic disorders (220)
Neuroscience (639)
NextGen Class of 2024 (2232)
Non-profit (1470)
Northern California (754)
Obesity (128)
Opinion (59)
People (9044)
Phase I (7884)
Phase II (12516)
Phase III (11073)
Pipeline (267)
Postmarket research (1259)
Preclinical (2633)
Radiopharmaceuticals (115)
Rare diseases (83)
Real estate (1141)
Regulatory (7078)
Research institute (719)
Resumes & cover letters (197)
Southern California (654)
Startups (789)
United States (6082)
Vaccines (247)
Weight loss (94)
Date
Today (174)
Last 7 days (792)
Last 30 days (2131)
Last 365 days (17614)
2024 (15743)
2023 (17835)
2022 (21574)
2021 (22719)
2020 (20355)
2019 (17978)
2018 (12805)
2017 (12137)
2016 (10390)
2015 (12659)
2014 (9071)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (276)
Arizona (45)
Asia (14044)
Australia (2147)
California (1610)
Canada (581)
China (116)
Colorado (61)
Connecticut (67)
Delaware (49)
Europe (32915)
Florida (202)
Georgia (44)
Illinois (141)
Indiana (83)
Japan (41)
Kansas (43)
Maryland (240)
Massachusetts (1255)
Michigan (45)
Minnesota (100)
New Hampshire (40)
New Jersey (448)
New York (454)
North Carolina (267)
Northern California (754)
Ohio (55)
Pennsylvania (372)
South America (428)
Southern California (654)
Texas (212)
Utah (36)
Washington State (176)
231,707 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Philips completes cancellation of 4.4 million shares
Royal Philips announced that it has completed the cancellation of 4,437,164 of its shares.
June 19, 2024
·
1 min read
Press Releases
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Biospecimen Market To Exceed $13.5 Billion USD By 2032
November 8, 2024
·
4 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
IPO
Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work
Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease work, while CAMP4 Therapeutics picked up $75 million to develop RNA-targeting drugs.
October 11, 2024
·
1 min read
·
Annalee Armstrong
Drug Development
4DMT Unveils More Positive Data for Wet AMD Candidate
Mid-stage data for
4D Molecular Therapeutics’ wet AMD drug 4D-150 show improvements in visual acuity, reduced injection rate and encouraging safety data.
July 17, 2024
·
2 min read
·
Tyler Patchen
Biotech Bay
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geographic Atrophy
4D Molecular Therapeutics today announced U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug Application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine, for the treatment of patients with GA.
June 24, 2024
·
7 min read
Gene therapy
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
4D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for annualized standard-of-care injections in patients with wet age-related macular degeneration.
September 19, 2024
·
2 min read
·
Tristan Manalac
Deals
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024
X4 Pharmaceuticals today announced that, effective on May 31, 2024, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc.
June 3, 2024
·
1 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2024
November 5, 2024
·
1 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 1, 2024
November 4, 2024
·
1 min read
1 of 23,171
Next
